Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%

Healthcare

Page 83
  1. Dec 18, 2025 · 16:06 · TELO

    Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program

    Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program

    01
  2. Dec 18, 2025 · 13:35 · CHS

    Comprehensive Healthcare Systems Inc. Signs a 5-Year Benefits and Pension Administration Agreement with Amalgamated Life Insurance Company, a Member of the Amalgamated Family of Companies

    Comprehensive Healthcare Systems Inc. Signs a 5-Year Benefits and Pension Administration Agreement with Amalgamated Life Insurance Company, a Member of the Amalgamated Family of Companies

    02
  3. Dec 18, 2025 · 13:00 · NURS

    Hydreight tops 1.3M orders ahead of 2025 target

    Hydreight tops 1.3M orders ahead of 2025 target

    03
  4. Dec 18, 2025 · 12:29 · HELP

    Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq

    Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq

    04
  5. Dec 18, 2025 · 08:45 · CNVI

    Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants

    Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants

    05
  6. Dec 18, 2025 · 08:30 · AIAI

    NetraMark Delivers Transformational Quarter Of Execution

    NetraMark Delivers Transformational Quarter Of Execution

    06
  7. Dec 18, 2025 · 07:46 · MBX

    Microbix Reports Results for Q4 and Fiscal 2025

    Microbix Reports Results for Q4 and Fiscal 2025

    07
  8. Dec 18, 2025 · 07:31 · APLI

    Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

    Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

    08
  9. Dec 18, 2025 · 07:30 · BCT

    "Eleven clinical trials that will shape medicine in 2026" - BriaCell Phase 3 Trial Featured in Nature Medicine

    "Eleven clinical trials that will shape medicine in 2026" - BriaCell Phase 3 Trial Featured in Nature Medicine

    09
  10. Dec 18, 2025 · 07:30 · GUD

    Knight Therapeutics Announces Health Canada Approval for WYNZORA(TM) to Treat Psoriasis Vulgaris

    Knight Therapeutics Announces Health Canada Approval for WYNZORA(TM) to Treat Psoriasis Vulgaris

    10
  11. Dec 18, 2025 · 07:25 · KNE

    Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

    Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

    11
  12. Dec 18, 2025 · 07:03 · THRM

    Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

    Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

    12
  13. Dec 18, 2025 · 07:00 · NURS

    Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

    Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

    13
  14. Dec 18, 2025 · 07:00 · VST

    Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

    Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

    14
← Newer Older →